Mammaglobin-A precursor (4-12)

Mammaglobin-A precursor (4-12) is a synthetic peptide fragment derived from the human mammaglobin-A protein, a member of the secretoglobin family with recognized tissue specificity for mammary epithelium. This particular peptide sequence, comprising amino acids 4 through 12 of the precursor, is valued for its role in molecular biology and biochemical research, especially in the context of breast tissue-specific markers. Its defined sequence and origin make it a valuable tool for applications in peptide mapping, epitope characterization, and antibody development, supporting advanced investigations into protein function, expression, and interactions relevant to mammary gland biology.

Epitope mapping: As a defined segment of the mammaglobin-A protein, the peptide is frequently employed in epitope mapping studies. Researchers utilize this fragment to identify and characterize antibody binding sites, enabling the precise localization of immunogenic regions within the parent protein. Such mapping is critical for understanding immune recognition patterns and for the rational design of monoclonal antibodies specific to mammaglobin-A, which is particularly relevant in the analysis of tissue-specific expression in breast tissue research.

Antibody validation: The peptide serves as a highly specific antigen in the validation and quality assessment of mammaglobin-A-targeted antibodies. By providing a well-characterized sequence, it allows for the evaluation of antibody specificity and affinity in immunoassays such as ELISA, Western blotting, or immunohistochemistry. This ensures that antibodies raised against mammaglobin-A recognize the intended epitope, minimizing cross-reactivity and enhancing the reliability of downstream analytical or detection applications.

Peptide-based assay development: The defined nature and sequence fidelity of the peptide make it suitable for use as a calibrator or positive control in peptide-based assays. Researchers can incorporate it into quantitative or qualitative platforms to standardize detection protocols, assess assay sensitivity, and optimize assay conditions. Such applications are particularly valuable in high-throughput screening or in the development of diagnostic research tools targeting mammaglobin-A expression patterns in experimental models.

Protein interaction studies: The peptide fragment enables targeted investigation of protein-protein or protein-ligand interactions involving the mammaglobin-A sequence. By synthesizing and immobilizing the peptide, researchers can probe the binding affinity and specificity of candidate interaction partners, such as receptors, binding proteins, or small molecules. These studies facilitate the elucidation of molecular mechanisms underlying mammaglobin-A function and its potential roles in mammary gland physiology.

Peptide structure-function analysis: The availability of a discrete mammaglobin-A-derived peptide supports structure-function relationship studies, allowing researchers to dissect the contributions of specific sequence motifs to overall protein activity. Through techniques such as alanine scanning or site-directed mutagenesis, the fragment can be systematically modified to assess the impact of individual residues on binding, stability, or biological activity, advancing the understanding of mammaglobin-A's structural determinants and functional domains.

1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

2. Emu oil in combination with other active ingredients for treating skin imperfections

3. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

4. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

5. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis